Dennis J. Selkoe - 03 May 2023 Form 4 Insider Report for PROTHENA CORP PUBLIC LTD CO (PRTA)

Role
Director
Signature
/s/ Michael J. Malecek, as attorney-in-fact for Dennis J. Selkoe
Issuer symbol
PRTA
Transactions as of
03 May 2023
Net transactions value
-$583,890
Form type
4
Filing time
05 May 2023, 21:30:46 UTC
Previous filing
27 May 2022
Next filing
19 May 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PRTA Ordinary Shares, par value $0.01 per share Options Exercise $55,380 +6,000 +211% $9.23* 8,845 03 May 2023 Direct
transaction PRTA Ordinary Shares, par value $0.01 per share Options Exercise $215,730 +9,000 +102% $23.97 17,845 03 May 2023 Direct
transaction PRTA Ordinary Shares, par value $0.01 per share Sale $855,000 -15,000 -84% $57.00 2,845 03 May 2023 Direct F1
holding PRTA Ordinary Shares, par value $0.01 per share 1,363 03 May 2023 By wife

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PRTA Stock Option (Right to Buy) Options Exercise $0 -6,000 -100% $0.000000* 0 03 May 2023 Ordinary Shares 6,000 $9.23 Direct F2
transaction PRTA Stock Option (Right to Buy) Options Exercise $0 -9,000 -60% $0.000000 6,000 03 May 2023 Ordinary Shares 9,000 $23.97 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The transactions reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 22, 2022.
F2 All shares subject to the option have fully vested.